PDE inhibitor, GSK256066, Purity ≥98%

Cat. No.: X24-08-YM491

PDE inhibitor, GSK256066, Purity ≥98%

Synonym: 801312-28-7; GSK-256066; 6-[3-(Dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide

  • MDL: MFCD18206923
  • CAS Number: 801312-28-7
  • Compound CID: 9827968
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
GSK256066, soluble in DMSO and insoluble in water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PDE. It targets the PDE4B.
Molecular Weight
518.6
Molecular Formula
C27H26N4O5S
Targets
PDE4B: 3.2 pM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 4 mg/mL (7.71 mM); Water: insoluble; Ethanol: insoluble; In vivo: 30% propylene glycol, 5% Tween 80, 65% D5W, 28 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
GSK256066 is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of inflammatory diseases such as chronic obstructive pulmonary disease (COPD) and asthma.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.